Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company specializing in local, controlled drug delivery using its Diffusphere™ technology, announced participation in upcoming investor conferences in New York and Toronto. The company is advancing clinical trials for its lead products, including EP-104GI for eosinophilic esophagitis and…